Malignancy and mortality in people with coeliac disease: population based cohort study

被引:252
作者
West, J [1 ]
Logan, RFA
Smith, CJ
Hubbard, RB
Card, TR
机构
[1] Univ Nottingham, Queens Med Ctr, Div Epidemiol & Publ Hlth, Nottingham NG7 2UH, England
[2] Univ Nottingham, City Hosp Nottingham, Sch Med & Surg Sci, Nottingham NG5 1PB, England
来源
BRITISH MEDICAL JOURNAL | 2004年 / 329卷 / 7468期
关键词
D O I
10.1136/bmj.38169.486701.7C
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To quantify the risks of malignancy and mortality in people with coeliac disease compared with the general population. Design Population based cohort study. Setting General practice research database. Participants 4732 people with coeliac disease and 23 620 matched controls. Main outcome measures Hazard ratios for malignancy and mortality. Results Of the 4732 people with coeliac disease, 134 (2.8%) had at least one malignancy and 237 (5.0%) died. The overall hazard ratios were: for any malignancy 1.29 (95% confidence interval 1.06 to 1.55), for mortality 1.31 (1.13 to 1.51), for gastrointestinal cancer 1.85 (1.22 to 2.81), for breast cancer 0.35 (0.17 to 0.72), for lung cancer 0.34 (0.13 to 0.95), and for lymphoproliferative disease 4.80 (2.71 to 8.50). The increased risk was primarily in the first year after diagnosis, with only the risk for lymphoproliferative disease remaining significantly raised thereafter. After excluding events in the year after diagnosis, the hazard ratio for malignancy was 1.10 (0.87 to 1.39) and for mortality was 1.17 (0.98 to 1.38), giving absolute excess rates of 6 and 17 per 10 000 person years, respectively. Conclusions People with coeliac disease have modest increases in overall risks of malignancy and mortality. Most of this excess risk occurs in the first year after diagnosis. People with coeliac disease also have a noticeably reduced risk of breast cancer. The mechanism of this merits further attention as it may provide insights into the cause of this common malignancy.
引用
收藏
页码:716 / 718A
页数:4
相关论文
共 21 条
[1]   Cancer incidence in a population-based cohort of individuals hospitalized with Celiac disease or dermatitis herpetiformis [J].
Askling, J ;
Linet, M ;
Gridley, G ;
Halstensen, TS ;
Ekström, K ;
Ekbom, A .
GASTROENTEROLOGY, 2002, 123 (05) :1428-1435
[2]   Risk of non-Hodgkin lymphoma in celiac disease [J].
Catassi, C ;
Fabiani, E ;
Corrao, G ;
Barbato, M ;
De Renzo, A ;
Carella, AM ;
Gabrielli, A ;
Leoni, P ;
Carroccio, A ;
Baldassarre, M ;
Bertolani, P ;
Caramaschi, P ;
Sozzi, M ;
Guariso, G ;
Volta, U ;
Corazza, GR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (11) :1413-1419
[3]   CELIAC-DISEASE AND MALIGNANCY [J].
COOPER, BT ;
HOLMES, GKT ;
FERGUSON, R ;
COOKE, WT .
MEDICINE, 1980, 59 (04) :249-261
[4]   Mortality in patients with coeliac disease and their relatives:: a cohort study [J].
Corrao, G ;
Corazza, GR ;
Bagnardi, V ;
Brusco, G ;
Ciacci, C ;
Cottone, M ;
Guidetti, CS ;
Usai, P ;
Cesari, P ;
Pelli, MA ;
Loperfido, S ;
Volta, U ;
Calabró, A ;
Certo, M .
LANCET, 2001, 358 (9279) :356-361
[5]   Mortality and causes of death in celiac disease in a Mediterranean area [J].
Cottone, M ;
Termini, A ;
Oliva, L ;
Magliocco, A ;
Marrone, C ;
Orlando, A ;
Pinzone, F ;
Di Mitri, R ;
Rosselli, M ;
Rizzo, A ;
Pagliaro, L .
DIGESTIVE DISEASES AND SCIENCES, 1999, 44 (12) :2538-2541
[6]  
Faggiano F, 1997, IARC Sci Publ, P65
[7]  
HOHNES GK, 1989, GUT, V30, P333
[8]  
Hollowell J, 1997, Popul Trends, P36
[9]   VALIDATION OF INFORMATION RECORDED ON GENERAL-PRACTITIONER BASED COMPUTERIZED DATA RESOURCE IN THE UNITED-KINGDOM [J].
JICK, H ;
JICK, SS ;
DERBY, LE .
BRITISH MEDICAL JOURNAL, 1991, 302 (6779) :766-768
[10]   Calcium-channel blockers and risk of cancer [J].
Jick, H ;
Jick, S ;
Derby, LE ;
Vasilakis, C ;
Myers, MW ;
Meier, CR .
LANCET, 1997, 349 (9051) :525-528